This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isasi, C. R.
Right arrow Articles by Berglund, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isasi, C. R.
Right arrow Articles by Berglund, L.
Related Collections
Right arrow Nutrition & Metabolism

PEDIATRICS Vol. 106 No. 3 September 2000, pp. 568-575

Apolipoprotein epsilon 2 Allele Is Associated With an Anti-atherogenic Lipoprotein Profile in Children: The Columbia University BioMarkers Study

Received Oct 25, 1999; accepted Jan 31, 2000.

Carmen R. Isasi*, Steven Shea*, Richard J. DeckelbaumDagger , Sarah C. CouchDagger , , Thomas J. StarcDagger , James D. Otvos§, and Lars Berglund*

From the Departments of * Medicine and Dagger  Pediatrics, Columbia University, New York, New York, and the Department of § Biochemistry, North Carolina State University, Raleigh, North Carolina.

Objective.  We examined associations between allelic variation in the apo epsilon  gene, which codes for apolipoprotein E, and plasma lipid levels in children.

Materials and Methods.  We analyzed genotype and fasting lipid levels, including lipid particle size by nuclear magnetic resonance spectroscopy, in 515 children from 297 families.

Results.  Children carrying the apo epsilon 2 allele (1 or 2 epsilon 2 alleles; n = 45) had higher mean high-density lipoprotein (HDL) cholesterol level (49.5 ± 13.0 vs 42.4 ± 8.9 mg/dL) and lower mean low-density lipoprotein (LDL) cholesterol level (82.2 ± 48.6 vs 105.9 ± 45.0 mg/dL) compared with apo epsilon 3/epsilon 3 children (n = 322). Mean HDL size was larger and mean level of the atheroprotective large HDL subpopulation was higher among apo epsilon 2 carriers compared with epsilon 3/epsilon 3 children (9.5 ± 0.4 vs 9.3 ± .4 nm, and 32.8 ± 9.9 vs 27.6 ± 8.2 mg/dL). In multivariate models adjusting for age, sex, ethnicity, family history, body mass index, and fasting triglyceride level, the apo epsilon 2 allele was independently predictive of higher levels of HDL cholesterol and the large HDL subpopulation and of lower level of LDL cholesterol.

Conclusion.  The apo epsilon 2 allele is associated with an anti-atherogenic lipid pattern in children.apolipoprotein epsilon , children, cholesterol. .




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
B. Kaess, M. Fischer, A. Baessler, K. Stark, F. Huber, W. Kremer, H. R. Kalbitzer, H. Schunkert, G. Riegger, and C. Hengstenberg
The lipoprotein subfraction profile: heritability and identification of quantitative trait loci
J. Lipid Res., April 1, 2008; 49(4): 715 - 723.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Djousse, J. S Pankow, D. K Arnett, J. H Eckfeldt, R. H Myers, and R C. Ellison
Apolipoprotein E polymorphism modifies the alcohol-HDL association observed in the National Heart, Lung, and Blood Institute Family Heart Study
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1639 - 1644.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Bosse, L. Perusse, and M.-C. Vohl
Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations
J. Lipid Res., June 1, 2004; 45(6): 1008 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C Infante-Rivard, E Levy, G-E Rivard, M Guiguet, and J-C Feoli-Fonseca
Small babies receive the cardiovascular protective apolipoprotein {varepsilon}2 allele less frequently than expected
J. Med. Genet., August 1, 2003; 40(8): 626 - 629.
[Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Rask-Nissila, E. Jokinen, J. Viikari, A. Tammi, T. Ronnemaa, J. Marniemi, P. Salo, T. Routi, H. Helenius, I. Valimaki, et al.
Impact of Dietary Intervention, Sex, and Apolipoprotein E Phenotype on Tracking of Serum Lipids and Apolipoproteins in 1- to 5-Year-Old Children: The Special Turku Coronary Risk Factor Intervention Project (STRIP)
Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 492 - 498.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
P. J. Talmud, L. Berglund, E. M. Hawe, D. M. Waterworth, C. R. Isasi, R. E. Deckelbaum, T. Starc, H. N. Ginsberg, S. E. Humphries, and S. Shea
Age-Related Effects of Genetic Variation on Lipid Levels: The Columbia University BioMarkers Study
Pediatrics, September 1, 2001; 108(3): e50 - 50.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Berglund
The APOE gene and diets--food (and drink) for thought
Am. J. Clinical Nutrition, April 1, 2001; 73(4): 669 - 670.
[Full Text] [PDF]